F E Psarakis
Overview
Explore the profile of F E Psarakis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
28
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pappa C, Alexandrakis M, Boula A, Psarakis F, Kolovou A, Bantouna V, et al.
Hematol Oncol
. 2013 Apr;
31(4):201-5.
PMID: 23576184
Angiogenesis is an essential process for the expansion of multiple myeloma (MM), in which many angiogenic factors participate. Endoglin (CD105) is a transforming growth factor-β co-receptor, being mainly expressed in...
2.
Pappa C, Tsirakis G, Psarakis F, Kolovou A, Tsigaridaki M, Stafylaki D, et al.
Med Oncol
. 2012 Dec;
30(1):363.
PMID: 23266941
There are many growth factors influencing the expansion of multiple myeloma (MM). Angiogenesis is a process that may enhance MM growth, in various manners. Among them, insulin-like growth factor-1 (IGF-1)...
3.
Tsirakis G, Pappa C, Spanoudakis M, Chochlakis D, Alegakis A, Psarakis F, et al.
Eur J Intern Med
. 2012 May;
23(4):368-73.
PMID: 22560388
Background: Τhe importance of angiogenesis in malignancies' growth is well recognized. CD105 (Endoglin), a proliferation-associated glycoprotein, is a powerful marker of neovascularization. Elevated amounts of soluble CD105 (sCD105) have been...
4.
Tsirakis G, Pappa C, Psarakis F, Fragioudaki M, Tsioutis C, Stavroulaki E, et al.
Med Oncol
. 2012 Mar;
29(4):2396-401.
PMID: 22403003
Multiple myeloma (MM) is a disease of plasma cells that express the CD40 receptor. Binding of the CD40 by its natural ligand, CD40 ligand (CD40L), produces growth arrest and/or apoptosis...